Skip to main
VCYT
VCYT logo

Veracyte (VCYT)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Veracyte (VCYT) Stock

About Veracyte (VCYT)

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in S...read more
Market cap$2.07B
Today's volume953.6K
Revenue (TTM)$463.39M
Avg. daily volume1.01M
EBITDA (TTM)$52.14M
Open$26.39
Price / earnings ratio63.03x
Today's range$26.2 - $27.01
Debt / equity4.23x
52 week range$19.73 - $47.32
5 year debt / equity1.84x
Beta (LTM)1.29x
Interest coverage16606.5x
Dividend & yield$0.00 (0.00%)
Current ratio5.1x
Ex-dividend date
Next earningsAug 5, 2025
Dividend payable date

Veracyte Stock Rating

What analysts recommend for VCYT stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 40%
Buy 47%
Hold 7%
Sell 7%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for Veracyte stock is $2.08B

The current P/E ratio for Veracyte stock is 63.03

The 52-week high for Veracyte stock is $47.32. The current Veracyte stock price $undefined is 100.00% below its 52-week high

The 52-week low for Veracyte stock is $19.73. The current Veracyte stock price $undefined has increased 100.00% from its 52-week low

No, the Veracyte stock does not pay dividends to its shareholders

The target price for Veracyte stock is $36.53 based on the average of what a group of analyst think Veracyte stock could be worth at a future date. This is not a prediction by Public.com

How to buy Veracyte stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in Veracyte stock

    Navigate to the Explore page. Then, type Veracyte into the search bar. When you see Veracyte stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased Veracyte stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Veracyte Stock Earnings

The value each VCYT share was expected to gain vs. the value that each VCYT share actually gained.

Veracyte (VCYT) reported Q1 2025 earnings per share (EPS) of $0.31, beating estimates of $0.20 by 55.00%. In the same quarter last year, Veracyte's earnings per share (EPS) was -$0.02. Veracyte is expected to release next earnings on 08/05/2025, with an earnings per share (EPS) estimate of $0.

Buy Veracyte (VCYT) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.